However, when the direction of effect is opposite (as seen for some genes and cathepsins, such as CTSF and CTSZ in in situ breast cancer), this indicates the possibility of compensatory mechanisms, where other factors might counterbalance the effect of gene expression or cathepsins. This evidence concerns the gene CTSF and breast carcinoma in situ.